Kemp PR - Search Results

1

A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer.

Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, Luben RN, Chang-Claude J, Mannermaa A, Kataja V, Pharoah PD, Easton DF, Ponder BA, Metcalfe JC. Dunning AM, et al. Among authors: kemp pr. Cancer Res. 2003 May 15;63(10):2610-5. Cancer Res. 2003. PMID: 12750287

2

Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer.

Lücke CD, Philpott A, Metcalfe JC, Thompson AM, Hughes-Davies L, Kemp PR, Hesketh R. Lücke CD, et al. Among authors: kemp pr. Cancer Res. 2001 Jan 15;61(2):482-5. Cancer Res. 2001. PMID: 11212236

3

Regulated tissue-specific alternative splicing of enhanced green fluorescent protein transgenes conferred by alpha-tropomyosin regulatory elements in transgenic mice.

Ellis PD, Smith CW, Kemp P. Ellis PD, et al. J Biol Chem. 2004 Aug 27;279(35):36660-9. doi: 10.1074/jbc.M405380200. Epub 2004 Jun 11. J Biol Chem. 2004. PMID: 15194683 Free article.

4

Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice.

Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC. Grainger DJ, et al. Among authors: kemp pr. Nature. 1994 Aug 11;370(6489):460-2. doi: 10.1038/370460a0. Nature. 1994. PMID: 8047165

5

Adhesion of endothelial cells to NOV is mediated by the integrins alphavbeta3 and alpha5beta1.

Ellis PD, Metcalfe JC, Hyvönen M, Kemp PR. Ellis PD, et al. Among authors: kemp pr. J Vasc Res. 2003 May-Jun;40(3):234-43. doi: 10.1159/000071887. J Vasc Res. 2003. PMID: 12902636

6

Selective modulation of the SM22alpha promoter by the binding of BTEB3 (basal transcription element-binding protein 3) to TGGG repeats.

Martin KM, Ellis PD, Metcalfe JC, Kemp PR. Martin KM, et al. Among authors: kemp pr. Biochem J. 2003 Oct 15;375(Pt 2):457-63. doi: 10.1042/BJ20030870. Biochem J. 2003. PMID: 12848620 Free PMC article.

7

The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis.

Grainger DJ, Kemp PR, Metcalfe JC, Liu AC, Lawn RM, Williams NR, Grace AA, Schofield PM, Chauhan A. Grainger DJ, et al. Among authors: kemp pr. Nat Med. 1995 Jan;1(1):74-9. doi: 10.1038/nm0195-74. Nat Med. 1995. PMID: 7584958

8

Genetic control of the circulating concentration of transforming growth factor type beta1.

Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD. Grainger DJ, et al. Among authors: kemp pr. Hum Mol Genet. 1999 Jan;8(1):93-7. doi: 10.1093/hmg/8.1.93. Hum Mol Genet. 1999. PMID: 9887336

9

Four isoforms of serum response factor that increase or inhibit smooth-muscle-specific promoter activity.

Kemp PR, Metcalfe JC. Kemp PR, et al. Biochem J. 2000 Feb 1;345 Pt 3(Pt 3):445-51. Biochem J. 2000. PMID: 10642500 Free PMC article.

10

Increased actin polymerization reduces the inhibition of serum response factor activity by Yin Yang 1.

Ellis PD, Martin KM, Rickman C, Metcalfe JC, Kemp PR. Ellis PD, et al. Among authors: kemp pr. Biochem J. 2002 Jun 1;364(Pt 2):547-54. doi: 10.1042/BJ20020269. Biochem J. 2002. PMID: 12023898 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters